Bionano Genomics, Inc. (NASDAQ: BNGO) today reported certain unaudited preliminary financial results and commercial highlights for the fourth quarter and fiscal year ended December 31, 2025. "2025 was ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback